کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2541315 1122651 2012 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Zaprinast activates MAPKs, NFκB, and Akt and induces the expressions of inflammatory genes in microglia
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Zaprinast activates MAPKs, NFκB, and Akt and induces the expressions of inflammatory genes in microglia
چکیده انگلیسی

Previously, the authors reported that zaprinast, an inhibitor of cGMP-selective phosphodiesterases, induced the secretions of TNF-α and IL-1β by microglia and enhanced the induction of iNOS by lipopolysaccharide (LPS). In this study, the signaling mechanism responsible for microglial activation by zaprinast was investigated and the effects of zaprinast and LPS on microglial activation were compared. Zaprinast was found to activate ERK1/2, p38 MAPK, JNK, NFκB, and PI3K/Akt, and subsequently, induce the mRNA expressions of IL-1α, IL-1β, TNF-α, CCL2, CCL4, CXCL1, CXCL2, and CD14. Associations between signaling pathways and gene expressions were examined by treating microglia with signal inhibitors. PDTC inhibited the induction of all the above genes by zaprinast, and SB203580 inhibited all genes except CXCL1. SP600125, PD98059, and LY294002 inhibited the induction of at least CCL2. Microglial activation by zaprinast was then compared with full-blown activation by LPS. The zaprinast-induced phosphorylations of MAPKs and IκB were less prompt than LPS-induced phosphorylations. IκB degradation by LPS was significant at 10 min and did not return to normal, whereas zaprinast induced a later, transient degradation. LPS induced the mRNA expressions of IL-1β, TNF-α, IL-6, CCL2, iNOS, and COX-2, and although zaprinast significantly induced the expressions of all except IL-6 and iNOS, these inductions were far less than those induced by LPS. Collectively, zaprinast was found to upregulate microglial activity mainly via NFκB and p38 MAPK signaling and the subsequent expressions of inflammatory genes. Although, zaprinast was found to have obvious effects on microglia, these were weaker than the effects of LPS.


► Zaprinast is a well-known inhibitor of cGMP-selective phosphodiesterases.
► We report its novel pharmacological effects on primary cultures of microglia.
► It activates ERK1/2, p38 MAPK, JNK, NFκB, and PI3K/Akt.
► Subsequently, it induces the mRNA expressions of several inflammatory genes.
► Although zaprinast has obvious effects on microglia, these are weaker than that of LPS.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Immunopharmacology - Volume 13, Issue 3, July 2012, Pages 232–241
نویسندگان
, , , , , , ,